Norway vs Slovakia: The number of people with susceptibility test result for rifampicin
Norway
69
in 2021
Slovakia
65
in 2021
Norway rank
114th
Slovakia rank
116th
The number of people with susceptibility test result for rifampicin over time
- Norway
- Slovakia
How they compare
Norway currently reports 69 against 65 in Slovakia, a difference of 4.
That makes Norway's figure about 1.1 times Slovakia's.
The two have swapped places 2 times across 5 shared years of data; in 2017 it was Norway ahead.
Norway ranks 114th and Slovakia ranks 116th of 155 countries.
Norway has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Norway | Slovakia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 105.33 | 97.67 | 7.67 | Norway |
| 2020s | 75 | 58 | 17 | Norway |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Norway or Slovakia?
- Norway, at 69 against 65 in Slovakia as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Norway and Slovakia?
- 4, with Norway ahead.
- How many years of comparable data are there for Norway and Slovakia?
- 5 years are reported by both, from 2017 to 2021.
- How do Norway and Slovakia rank globally for the number of people with susceptibility test result for rifampicin?
- Norway ranks 114th and Slovakia ranks 116th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.